Skip to main content

Advertisement

Log in

Dehydroepiandrosterone and Dehydroepiandrosterone Sulphate in Atopic Allergy and Chronic Urticaria

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The increasing amounts of evidence prove that sex hormones modulate different cells function, including mast cells and lymphocytes. Dehydroepiandrosterone (DHEA) and its sulphate ester (DHEA-S) are both the secretory products of adrenal glands and the most abundant hormones in the systemic circulation of humans, converted then into androgens and estrogens in the periphery. DHEA may affect production of Th1 and Th2- associated cytokines, suggesting their significance in diseases where imbalanced lymphocyte activity plays the essential role, also in atopic diseases. Reduced circulating concentration of these androgens has been demonstrated in patients with immune-inflammatory diseases, including atopic eczema/dermatitis syndrome and asthma. It is unknown however, whether such changes contribute in any way to etiopathogenesis of the disorders, or are merely their consequences. Chronic urticaria, not included in the atopic triad, is a mast cell-dependent disease characterised by activation of autoimmune and inflammatory processes responding to different factors. Alterations in the immune-neuro-endocrine milieu may contribute to the development of the disease. It has been demonstrated that DHEA-S concentration is significantly lower in the peripheral circulation of patients suffering from chronic urticaria, as compared with healthy subjects. On one hand, this reflects some changes in hormonal homeostasis in the course of urticarial processes, yet on the other, suggests some possible role for this hormone in pathophysiology of the disease. In this brief review we present the available data on DHEA-S involvement in events associated with atopic allergy as well as chronic urticaria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AEDS:

atopic eczema/dermatitis syndrome

DHEA:

dehydroepiandrosterone

DHEA-S:

dehydroepiandrosterone sulphate

DHEA(-S):

dehydroepiandrosterone and dehydroepiandrosterone sulphate

References

  1. Wilder, R. L. 1995. Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 13:307–338.

    Article  PubMed  CAS  Google Scholar 

  2. Hamano, N., N. Terada, K. Maesako, T. Numata, and A. Konno. 1998. Effect of sex hormones on eosinophilic inflammation in nasal mucosa. Allergy Asthma Proc. 19:263–269.

    Article  PubMed  CAS  Google Scholar 

  3. Lima, A. P., L. O. Lunardi, and A. A. Rosa e Silva. 2000. Effects of castration and testosterone replacement on peritoneal histamine concentration and lung histamine concentration in pubertal male rats. J. Endocrinol. 167:71–75.

    Article  PubMed  CAS  Google Scholar 

  4. Daynes, R. A., D. J. Dudley, and B. A. Araneo. 1990. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur. J. Immunol. 20:793–802.

    Article  PubMed  CAS  Google Scholar 

  5. Pawlikowski, M. 2005. Adrenal cortex—the next biological clock. Neuro. Endocrinol. Lett. 26:193–195.

    PubMed  CAS  Google Scholar 

  6. Rook, G. A., R. Hernandez-Pando, and S. L. Lightman. 1994. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol. Today 15:301–303.

    Article  PubMed  CAS  Google Scholar 

  7. Kroboth, P. D., F. S. Salek, A. L. Pittenger, T. J. Fabian, and R. F. Frye. 1999. DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39:327–348.

    Article  PubMed  CAS  Google Scholar 

  8. Burger, H. G., E. C. Dudley, J. Cui, L. Dennerstein, and J. L. Hopper. 2000. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulphate and sex hormone binding globulin levels through the menopause transition. J. Clin. Endocrinol. Metab. 85:2832–2938.

    Article  PubMed  CAS  Google Scholar 

  9. Burger, H. G. 2002. Androgen production in women. Fertill. Steril. 77(Suppl 4):S3–S5.

    Article  Google Scholar 

  10. Lucas, J. A., S. A. Ahmed, M. L. Casey, and P. C. MacDonald. 1985. Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice fed dehydroisoandrosterone. J. Clin. Invest. 75:2091–2093.

    Article  PubMed  CAS  Google Scholar 

  11. Dillon, J. S. 2005. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr. Drug Targets Inflamm. Allergy 4:377–385.

    Article  PubMed  CAS  Google Scholar 

  12. Cutolo, M., B. Seriolo, B. Villaggio, C. Pizzorni, C. Craviotto, and A. Sulli. 2002. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 966:131–142.

    PubMed  CAS  Google Scholar 

  13. Du, C., M. W. Khalil, and S. Sriram. 2001. Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. J. Immunol. 167:7094–7101.

    PubMed  CAS  Google Scholar 

  14. Straub, R. H., A. Schuld, J. Mullington, M. Haack, J. Schölmerich, and T. Pollmacher. 2002. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. J. Endocrinol. 175:467–474.

    Article  PubMed  CAS  Google Scholar 

  15. Romagnani, S. 2000. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85:9–21.

    Article  PubMed  CAS  Google Scholar 

  16. Suzuki, T., N. Suzuki, R. A. Daynes, and E. G. Engleman. 1991. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin. Immunol. Immunopathol. 61:202–211.

    Article  PubMed  CAS  Google Scholar 

  17. Tabata, N., H. Tagami, and T. Terui. 1997. Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis. Arch. Dermatol. Res. 289:410–414.

    Article  PubMed  CAS  Google Scholar 

  18. Sudo, N., X. N. Yu, and C. Kubo. 2001. Dehydroepiandrosterone attenuates the spontaneous elevation of serum IgE level in NC/Nga mice. Immunol. Letters 79:177–179.

    Article  CAS  Google Scholar 

  19. Yu, C. K., B. C. Yang, H. Y. Lei, Y. C. Chen, Y. H. Liu, C. C. Chen, and C. W. Liu. 1999. Attenuation of house dust mite Dermatophagoides farinae-induced airway allergic responses in mice by dehydroepiandrosterone is correlated with down-regulation of Th2 response. Clin. Exp. Allergy 29:414–422.

    Article  PubMed  CAS  Google Scholar 

  20. Yu, C. K., Y. H. Liu, and C. L. Chen. 2002. Dehydroepiandrosterone attenuates allergic airway inflammation in Dermatophagoides farinae-sensitized mice. J. Microbiol. Immunol. Infect. 35:199–202.

    PubMed  CAS  Google Scholar 

  21. Dashtaki, R., A. R. Whorton, T. M. Murphy, P. Chitano, W. Reed, and T. P. Kennedy. 1998. Dehydroepiandrosterone and analogs inhibit DNA binding of AP-1 and airway smooth muscle proliferation. J. Pharmacol. Exp. Ther. 285:876–883.

    PubMed  CAS  Google Scholar 

  22. Powell, J. M., and G. Sonnenfeld. 2006. Sonnenfeld. The effects of dehydroepiandrosterone (DHEA) on in vitro spleen cell proliferation and cytokine production. J. Interferon Cytokine Res. 26:34–39.

    Article  PubMed  CAS  Google Scholar 

  23. Ebata, T., R. Itamuram, H. Aizawa, and M. Niimura. 1996. Serum sex hormone levels in adult patients with atopic dermatitis. J. Dermatol. 23:603–605.

    PubMed  CAS  Google Scholar 

  24. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2007. Serum concentration of dehydroepiandrosterone sulfate and testosterone in female patients suffering from severe atopic/dermatitis syndrome (AEDS). J. Invest. Allergol. Clin. Immunnol. 17:160–163.

    CAS  Google Scholar 

  25. Dunn, P. J., C. B. Mahood, J. F. Speed, and D. R. Jury. 1984. Dehydroepiandrosterone sulphate concentrations in asthmatic patients: pilot study. N. Z. Med. J. 97:805–808.

    PubMed  CAS  Google Scholar 

  26. Kos-Kudla, B., Z. Ostrowska, B. Marek, N. Ciesielska-Kopacz, M. Kudla, D. Kajdaniuk, L. Siemidska, and J. Strzelczyk. 2001. Circadian serum levels of dehydroepiandrosterone sulphate in postmenopausal asthmatic women before and after long-term hormone replacement. Endocr. Regul. 35:217–222.

    PubMed  CAS  Google Scholar 

  27. Nogueira, J. M., L. P. Pinto, V. Loureiro, S. Prates, A. Gaspar, M. M. Almeida, and J. E. Pinto. 1998. Soluble CD30, dehydroepiandrosterone sulfate and dehydroepiandrosterone in atopic and non atopic children. Allerg Immunol. (Paris) 30:3–8.

    CAS  Google Scholar 

  28. Greaves, M. W. 1995. Chronic urticaria. N. Engl. J. Med. 332:1767–1772.

    Article  PubMed  CAS  Google Scholar 

  29. Confino-Cohen, R., A. Goldberg, D. Aharoni, L. Naiman, A. Buchs, M. Weiss, J. Weissgarten, and M. J. Rapoport. 2004. Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria. Cytokine 27:74–80.

    Article  PubMed  CAS  Google Scholar 

  30. Schwartz, K. E.. 2002. Autoimmunity, dehydroepiandrosterone (DHEA), and stress. J. Adolesc. Health 30S:37–43.

    Article  Google Scholar 

  31. Bertinotti, L., I. Miniati, and M. M. Cerinic. 2002. Angioedema and systemic sclerosis. A review of the literature. Scand. J. Rheumatol. 31:178–180.

    Article  PubMed  Google Scholar 

  32. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2006. Serum concentration of dehydroepiandrosterone sulphate in female patients with chronic idiopathic urticaria. J Dermatol. Sci. 41:80–81.

    Article  PubMed  CAS  Google Scholar 

  33. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2006. Lower serum concentration of dehydyroepiandrone sulphate in patients with chronic idiopathic urticaria. Allergy 61:1489–1490.

    Article  PubMed  CAS  Google Scholar 

  34. Brzoza, Z., A. Kasperska-Zajac, and B. Rogala. 2007. Serum prolactin concentration and its relationship with dehydroepiandrosterone sulfate concentration in chronic urticaria patients with positive and negative response to autologous serum skin test. Allergy 62:566–567.

    Article  PubMed  CAS  Google Scholar 

  35. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2007. Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria. Cytokine 39:142–146.

    Article  PubMed  CAS  Google Scholar 

  36. Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2007. Circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in women suffering from chronic idiopathic urticaria in relation to their pre- or post-menopausal status. Maturities 58:211–215.

    Article  CAS  Google Scholar 

  37. Kasperska-Zajac, A., Z. Brzoza, K. Badura-Brzoza, J. Matysiakiewicz, R. T. Hese, and B. Rogala. 2007. Does the dehydroepiandrosterone sulphate decline in chronic urticaria result from psychological distress. Allergy 62(s83):1640 poster.

    Google Scholar 

  38. Murakami, K., T. Nakagawa, G. Yamashiro, K. Araki, and K. Akasofu. 1993. Adrenal steroids in serum during danazol therapy, taking into account cross-reactions between danazol metabolites and serum androgens. Endocr. J. 40:659–664.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alicja Kasperska-Zajac.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kasperska-Zajac, A., Brzoza, Z. & Rogala, B. Dehydroepiandrosterone and Dehydroepiandrosterone Sulphate in Atopic Allergy and Chronic Urticaria. Inflammation 31, 141–145 (2008). https://doi.org/10.1007/s10753-008-9059-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-008-9059-1

Key words

Navigation